Nature Article Cites Cleanascite™ for Lipid Influences in Tumor-associated Macrophages

News Release


NatureArticle Cites Cleanascite™ for Lipid Influences in Tumor-associatedMacrophages


MONMOUTHJUNCTION, NJ,November15, 2021 -- Biotech Support Group reports on a research articledescribing the simplicity and efficiency of their lipid depletiontechnology to determine the influence of lipid composition andsaturation on the ER membrane of macrophages in tumors. The citationis:

DiConza, Giusy, et al. "Tumor-inducedreshuffling of lipid composition on the endoplasmic reticulummembrane sustains macrophage survival and pro-tumorigenicactivity." Natureimmunology (2021):1-13.

Tumor-associatedmacrophages (TAMs) display pro-tumorigenic phenotypes for supportingtumor progression in response to microenvironmental cues imposed bytumor and stromal cells. However, the underlying mechanisms by whichtumor cells instruct TAM behavior remain elusive. The investigatorshere uncover that tumor-cell-derived glucosylceramide stimulatedunconventional endoplasmic reticulum (ER) stress responses byinducing reshuffling of lipid composition and saturation on the ERmembrane in macrophages.

Aspart of the study, a comparison of culture media (CM) with andwithout lipids (woLip) was made. Thearticle states “To generate culture media without lipids, …CM wastreated with Cleanascite according to the manufacturer’sinstructions.”. The authorsuncover the unexpected roles of tumor-cell-produced lipids thatsimultaneously orchestrate macrophage polarization and survival intumors via induction of ER stress responses and reveal therapeutictargets for sustaining host antitumor immunity.

Itsvery rewarding to see how Cleanascite™ can enhance cancer researchassociated with the selective removal of lipids. Cleanascite™ is anaqueous suspension product without harmful solvents, or any othernon-specificcytotoxic effects.As you see from this data, it ultimately helps researchersinvestigate how lipids impart characteristic changes in cells. Thisarticle exemplifies such utility.” states Swapan Roy, Ph.D.,President and Founder of Biotech Support Group

Clickto download whitepaper entitled “Cleanascite™ - Lipid Removaland Cell Response Applications”

Clickto visit Cleanascite™product page and ordering information


AboutBiotech Support Group LLC

Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal,the company has acquired knowledgebase and biomarker intellectualproperty assets that support discoveries of protein markers fromblood, with special emphasis on early detection and personalizedmedical decisions for Covid-19 and cancer patients. For moreinformation, gotohttp://www.biotechsupportgroup.com.


ForBusiness Development,contact:MatthewKuruc 732-274-2866, [email protected]


Empty Cart